Leerink Partners
Overview
Leerink Partners is an independent investment bank founded in 1995 with an exclusive focus on the healthcare industry. The firm provides M&A advisory, equity and debt capital markets, equity research, and sales and trading services to companies in the biopharma, digital health, health tech, medical technology, and tools and diagnostics sectors. In addition to its banking services, the firm also engages in investment activities, having co-founded the VC firm Transformation Capital and established the Leerink Transformation Fund. The firm was acquired by SVB Financial Group in 2019 and operated as SVB Leerink and later SVB Securities, before a management buyout in 2023 restored its independence and original name.
Portfolio Companies
36
Website
leerink.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Revolution Medicines | Feb 2020 | IPO | Co-investor |
| Parabilis Medicines | May 2018 | Series B | Co-investor |
| Fog Pharmaceuticals | Jun 2026 | IPO | Lead |
| Kailera Therapeutics | Apr 2026 | IPO | Lead |
| Alumis Inc | Jun 2024 | IPO | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Leerink Partners based?
Leerink Partners is headquartered in Boston, Massachusetts, United States.
When was Leerink Partners founded?
Founding year information for Leerink Partners is not publicly available.
How many portfolio companies does Leerink Partners have?
Leerink Partners has 36 portfolio companies in Caplight's dataset.
What are some companies in Leerink Partners's portfolio?
Portfolio companies visible on Caplight include Revolution Medicines, Parabilis Medicines, Fog Pharmaceuticals, Kailera Therapeutics, Alumis Inc.
What was Leerink Partners's most recent investment shown here?
Leerink Partners's most recent investment in this portfolio sample was in Fog Pharmaceuticals in 2026.
What sectors does Leerink Partners focus on?
Leerink Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Leerink Partners focus on?
Leerink Partners typically invests at the MultiStage stage.